Danaher to acquire US CDMO Aldevron for $9.6bn
Danaher Corporation has agreed to acquire Aldevron, a North Dakota-based manufacturer of plasmid DNA, mRNA, and recombinant proteins, for nearly $9.6 billion from EQT Group’s ... Read More
Aldevron expands antibody development facility in Freiburg, Germany
Aldevron, a US-based contract development and manufacturing organisation (CDMO), has unveiled plans to expand its antibody development facility located in Freiburg, Germany. The Freiburg site, ... Read More